IP Library Granted Patent US 7,279,581
Granted Patent B2
US 7,279,581 · App. 10/509,918 · Granted Oct 9, 2007

Process for preparing a pharmaceutically active compound

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,279,581
App. No.
10/509,918
Granted
Oct 9, 2007
Kind
B2
Abstract

In particular, rizatriptan or a pharmaceutically acceptable salt thereof, which includes a) Preparation of the diazonium salt of aniline hydrochloride (II); followed by reduction and acidification to give the hydrazine (III); b) reaction in situ of the hydrazine hydrochloride (III) with α-keto-δ-valerolactone, to give the hydrazone (IV); c) Fischer indole reaction of the hydrazone (IV), to give the pyranoindolone (V), optionally followed by a hydrolysis reaction to give (VI); d) Transesterification of (V) or esterification of its hydrolysis product (VI), to give (VII), where R means straight or branched C1-C4 alkyl chain; e) Conversion of the hydroxyl group of (VII) into dimethylamino, to give the indolecarboxylate (VIII), where R has the meaning defined above; f) Saponification of the 2-carboalkoxy group of (VIII) to give indolecarboxylic acid (IX); and g) Decarboxylaton of the indolecarboxylic acid (IX) to give rizatriptan and, eventually, to obtain a pharmaceutically acceptable salt thereof. The invention also relates to synthesis intermediates to obtain rizatriptan.

Claims (29)

1. Process for preparing a pharmaceutically active compound, rizatriptan, or a pharmaceutically acceptable salt thereof, which comprises the following steps:

a) Preparation of the diazonium salt of the aniline hydrochloride of formula (II)

followed by reduction and acidification to give the hydrazine of formula (III):

b) In situ reaction of the hydrazine hydrochloride of formula (III) with α-keto-δ-valerolactone, to give the hydrazone of formula (IV):

c) Fischer indole reaction of the hydrazone of formula (IV), to give the pyranoindolone of formula (V):

followed optionally by hydrolysis to give the product of formula (VI):

d) Transesterification of the compound of formula (V) or esterification of its hydrolysis product of formula (VI), to give a compound of formula (VII):

where R represents a straight or branched C1-C4 alkyl chain;

e) conversion of the hydroxyl group of the compound of formula (VII) into dimethylamino, to give the indolecarboxylate of formula (VIII):

where R has the same meaning as defined above;

f) Saponification of the 2-carboalkoxy group of the compound of formula (VIII), to give the indolecarboxylic acid of formula (IX):

g) Decarboxylation of the indolecarboxylic acid of formula (IX), to give rizatriptan, and

eventually, the preparation of a pharmaceutically acceptable salt thereof.

2. Process according to claim 1 , wherein in step c) the indolisation is carried out in a solution of dry hydrogen chloride in a straight or branch C1-C4 alcohol chain.

3. Process according to claim 1 , wherein steps a), b) and c) are carried out as a one pot reaction.

4. Process according to claim 1 , wherein step c) is carried out in aqueous acid medium and is followed by a hydrolysis reaction to give the product of formula (VI).

5. Process according to claim 1 , wherein step e) is carried out in two steps:

e-i) substitution of the hydroxyl group of the compound of formula (VII) by a leaving group X; and

e-ii) subsequent substitution reaction of the leaving group X with dimethylamine to give the compound of formula (VIII).

6. Process according to claim 5 , wherein the leaving group X is selected from a halogen atom, a mesylate group or a tosylate group.

7. Process according to claim 1 , wherein step d) is carried out in an alcoholic solution and in the presence of an acid.

8. Process according to claim 1 , wherein a Synthesis intermediate of formula (IV):

9. Process according to claim 1 , wherein a Synthesis intermediate of formula (V):

10. Process according to claim 1 , wherein a Synthesis intermediate of formula (VI):

11. Process according to claim 1 , wherein a Synthesis intermediate of formula (VII):

where R represents a straight or branched C1-C4 alkyl chain.

12. Process according to claim 1 , wherein a Synthesis intermediate of formula (VIII):

where R represents a straight or branched C1-C4 alkyl chain.

13. Process according to claim 1 , wherein a Synthesis intermediate of formula (IX):

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2007
From: VITA CIENTIFICA, S.L.
To: INKE, S.A.
Reel/Frame 019773/0687 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2004
From: ARMENGOL ASPARO, MONTSERRAT; DALMASES BARJOAN, PERE
To: LABORATORIOS VITA, S.A.
Reel/Frame 016379/0819 →